Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer,
negatively expresses estrogen receptor, progesterone receptor, and the human epidermal …

Breast cancer (BC) is a multifaceted disease characterized by distinct molecular subtypes
and varying responses to treatment. In BC, the phosphatidylinositol 3-kinase (PI3K) pathway …

Breast cancer is the second leading cause of death in women worldwide, with triple-
negative breast cancer (TNBC) having the worst prognosis. Although there are numerous …

Purpose Triple-negative breast cancer (TNBC) is the most aggressive breast cancer
subgroup characterized by a high risk of resistance to chemotherapies and high relapse …

Even though chemotherapy stands as a standard option in the therapy of TNBC, problems
associated with it such as anemia, bone marrow suppression, immune suppression, toxic …

Simple Summary Salivary gland tumors (SGTs) are rare and complex, making them difficult
to diagnose and treat. This work focuses on the role of exosomes, extracellular vesicles …

Breast cancer (BC) remains a significant health burden worldwide, necessitating the
development of innovative therapeutic strategies. The B-cell lymphoma 2 (Bcl-2) family …

Background Triple-negative breast cancer (TNBC) is characterized by its high metastatic
potential, which results in poor patient survival. Cancer-associated fibroblasts (CAFs) are …

Breast cancer is still one of the major health concerns of today's world. In light of such a
scenario, regular improvement in the detection technique is crucial to meet better early …

Triple-negative breast cancer (TNBC) is one of the destructive breast cancer subtypes which
cannot be treated by current therapies, which is characterized by the lack of estrogen (ER) …